New Bill to Address Prescription Drug Shortages
We’ve all spent time looking at the expiration date labels in our fridge and pantry. Sometimes it's apparent that the food in question has gone bad, but sometimes it isn’t. And sometimes the product is fine past the date on the label. The same can be true for prescription drugs. That is the reason that U.S. Senators Susan Collins (R-ME) and Ben Cardin (D-MD) have introduced the Drug Shortages Shelf-Life Extension Act, a bipartisan bill that would direct the U.S. Food and Drug Administration (FDA) to extend the shelf life of prescription drugs in scarce supply.
Reporting by Jon Terry
January 20, 2022
Washington, D.C. – U.S. Senators Susan Collins (R-ME) and Ben Cardin (D-MD) introduced the Drug Shortages Shelf-Life Extension Act, a bipartisan bill that would direct the U.S. Food and Drug Administration (FDA) to extend the shelf life of prescription drugs in scarce supply. According to the FDA, amending the expiration date of some prescription drugs may alleviate the shortages that the United States currently is facing.
If enacted, this legislation could well safely extend the official expiration dates of epinephrine auto-injectors by months or even years.
“At a time when our health care system is overburdened by the COVID-19 pandemic, the last thing doctors, nurses, and patients should have to worry about is whether there will be an adequate supply of the medications they need,” said Senator Collins. “To help ensure all patients have access to lifesaving medications, our bipartisan legislation would update FDA guidance in order to safely extend the shelf life of essential drugs.”
“The U.S. is the wealthiest nation in the world; no one in this country should fall victim to prescription drug shortages,” said Senator Cardin. “The federal government must work to ensure that patients who rely on life-sustaining medications for the treatment of infections, cancer, autoimmune conditions, and for basic medical procedure necessities, like saline or epinephrine, will always have an adequate supply of the prescription drugs they need. No one should have to go without essential prescriptions drugs when usable supplies are available despite the date stamped on their box or bottle.”
As FDA noted in their 2019 Drug Shortages Task Force Report, shortages of essential drugs may be, “… exacerbated if drugs must be discarded because they exceed a labeled shelf-life based on unnecessarily short expiration dates.” The regulations that govern prescription drug shelf life testing have not been amended since 1981. Therefore, in order to ensure the accuracy of shelf life data, it is imperative that regulations governing shelf life stability testing are up-to-date.
The Drug Shortages Shelf-Life Extension Act would:
- Update FDA guidance regarding stability testing tied to shelf life expiration dates.
- Require the FDA to submit a report to the U.S. Committee on Health, Education, Labor and Pensions (HELP) Committee and House Energy and Commerce Committee including information on labeling changes regarding product expiration dates that the Secretary requests of manufacturers
Allergic individuals who must carry epinephrine auto-injectors often complain about the expense of having to replace them every year, this despite research published in a study from The Journal of Allergy and Clinical Immunology: In Practice that shows the majority of epinephrine auto-injectors retained over 90% concentration of epinephrine years after expiration dates, regardless of the manufacturer.
Original article reprinted with permission from Dave Bloom
Source: Collins, Cardin Introduce Bill to Address Prescription Drug Shortages — Collins.Senate.Gov